Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT00691964 · COMPLETED
Trial details
- NCT number
- NCT00691964
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-03-01
- Enrollment
- 347
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.